MUSA
Murphy USA Inc.
MUSA's fundamentals are strong: revenue grew 20% and free cash flow grew 82%. At 15x earnings, it's trading right at its usual valuation. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
NKE
NIKE, Inc.
NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
MUSA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Healthy |
MUSA's revenue, profitability, cash flow and balance sheet are all currently healthy.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
MUSA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $385 | -28% |
| Fair | 15x | $534 | -0.1% |
| Current | 15x | $535 | — |
| Forward | 18x | $535 | — |
| Expensive | 20x | $697 | +30% |
Historical ranges are pointers, not guarantees.
MUSA's PE is in its fair range at 15x. On analysts' estimates for next year's earnings, today's price would be 18x, in its expensive range.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over MUSA in the historical PE scenario, which offers more potential upside but is not a forecast.
MUSA Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Stable | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect MUSA's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
MUSA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.88 | -16% |
| Q3 2026 | $35.49 | +50% |
| Q2 2026 | $32.66 | +36% |
| Q1 2026 | $28.75 | +22% |
| Q4 2025 | $24.10 | 0% |
| Q3 2025 | $23.62 | -2.5% |
| Q2 2025 | $24.06 | -2.6% |
| Q1 2025 | $23.62 | -0.8% |
| Q4 2024 | $24.11 | -5.4% |
MUSA has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
MUSA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.9B | +35% |
| Q2 2026 | $6.8B | +36% |
| Q1 2026 | $4.8B | +6.5% |
| Q4 2025 | $4.7B | +0.7% |
| Q3 2025 | $5.1B | -2.5% |
| Q2 2025 | $5B | -8.2% |
| Q1 2025 | $4.5B | -6.6% |
| Q4 2024 | $4.7B | -7.1% |
MUSA has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.8% | -0.2 points |
| Q2 2026 | 4.5% | +0.1 points |
| Q1 2026 | 4.3% | +2.3 points |
| Q4 2025 | 4.4% | +0.2 points |
| Q3 2025 | 4% | -0.3 points |
| Q2 2025 | 4.4% | +0.4 points |
| Q1 2025 | 1.9% | -0.2 points |
| Q4 2024 | 4.2% | -0.1 points |
MUSA's operating margin was 3.8% last quarter, about level with the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over MUSA on profitability, with a higher operating margin.
MUSA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $193.7M | +186% |
| Q2 2026 | $123.3M | -10% |
| Q1 2026 | $221.7M | +445% |
| Q4 2025 | $128.8M | +5.8% |
| Q3 2025 | $67.7M | +3.8% |
| Q2 2025 | $137.1M | -4% |
| Q1 2025 | $40.7M | -32% |
| Q4 2024 | $121.7M | -25% |
MUSA has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
MUSA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -192K shares |
| 1 year | -4.5% | -872K shares |
| 3 years | -16% | -3.4M shares |
| 5 years | -30% | -7.8M shares |
| Available history | -42% | -13.5M shares |
MUSA has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $156.2M |
| Q2 2026 | $82.3M |
| Q1 2026 | $70.5M |
| Q4 2025 | $66.9M |
| Q3 2025 | $219.2M |
| Q2 2025 | $213.8M |
| Q1 2025 | $150M |
| Q4 2024 | $128M |
MUSA spent $376M buying back its own shares over the past year, down 47% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
MUSA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 2.2x | Moderate |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 2.0x | Healthy |
| Q4 2024 | 1.8x | Healthy |
MUSA's net debt is about 1.6 years of its operating earnings (EBITDA), down from 2.2 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over MUSA on leverage, with a lower net debt burden relative to earnings.
MUSA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 37.4 | Neutral |
MUSA's weekly RSI is 51 (neutral) and its Stochastic is 37 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
MUSA PE vs Consumer Cyclical Sector
| Metric | MUSA | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 16% below |
| PE % | 50 | 47 | 3 pts above |
MUSA has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
MUSA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $528.7 | 1.1% above |
| 20 week MA | $547.2 | 2.3% below |
| 50 week MA | $503.4 | 6.2% above |
| 100 week MA | $467.6 | 14% above |
| 200 week MA | $425.8 | 26% above |
MUSA has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
MUSA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $119.5 | $130.2 | +8.9% |
| 2021 | $130.2 | $191.6 | +47% |
| 2022 | $191.6 | $293.4 | +53% |
| 2023 | $293.4 | $356.6 | +22% |
| 2024 | $356.6 | $505.2 | +42% |
| 2025 | $505.2 | $405.0 | -20% |
| 2026 YTD | $405.0 | $534.7 | +32% |
MUSA has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.